<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02283736</url>
  </required_header>
  <id_info>
    <org_study_id>FONDECYT 1130570</org_study_id>
    <nct_id>NCT02283736</nct_id>
  </id_info>
  <brief_title>Efficacy of Oral Probiotic Administration in Patients With Chronic Periodontitis</brief_title>
  <acronym>probiotic</acronym>
  <official_title>Efficacy of Oral Probiotic Administration in Clinical, Immunological and Microbiological Parameters of Patients With Chronic Periodontitis Treated With Non Surgical Periodontal Treatment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jorge Gamonal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chile</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized placebo- controlled clinical trial is to evaluate the effects of
      Lactobacillus rhamnosus SP1- containing probiotic tablets as an adjunct to scaling and root
      planning (SRP).

      Material and methods: Thirty six chronic periodontitis patients will be recruited and
      monitored clinically, immunologically and microbiologically at baseline, 3 and 6 months after
      therapy. All patients will receive scaling and root planning and randomly will be assigned
      over an experimental (SRP + probiotic, n=18) or control (SRP + placebo, n=18) group. The
      tablets will be used once per day during 3 months.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences of at least 1mm between groups for clinical attachment level changes</measure>
    <time_frame>baseline, 3, 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences between groups for probing depth changes</measure>
    <time_frame>baseline, 3, 6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences between groups for bleeding on probing changes</measure>
    <time_frame>baseline, 3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences between groups for plaque index changes</measure>
    <time_frame>baseline, 3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences between groups for levels of Interleukin (IL)-17, IL-21, Transforming Growth Factor (TGF)- beta, IL-10, RANKL changes in gingival crevicular fluid</measure>
    <time_frame>baseline, 3, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences between groups for levels of periodontal pathogens changes</measure>
    <time_frame>baseline, 3, 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>-Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Periodontal treatment, Probitic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Periodontal treatment (scaling and root planning) and one tablet containing Lactobacillus rhamnosus SP1 per day during 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontal treatment, talc powder tab</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Periodontal treatment (scaling and root planning) and one tablet containing talc powder per day during 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lactobacillus rhamnosus SP1</intervention_name>
    <description>Tablet containing Lactobacillus rhamnosus SP1</description>
    <arm_group_label>Periodontal treatment, Probitic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Talc powder</intervention_name>
    <description>Tablet containing talc powder</description>
    <arm_group_label>Periodontal treatment, talc powder tab</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Periodontal treatment</intervention_name>
    <description>Scaling and root planning</description>
    <arm_group_label>Periodontal treatment, Probitic</arm_group_label>
    <arm_group_label>Periodontal treatment, talc powder tab</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥14 natural teeth, excluding third molars

          -  ≥10 posterior teeth

          -  ≥35 years old

          -  ≥ 5 teeth with periodontal sites with probing depths ≥5mm, clinical attachment loss
             ≥3mm

          -  Bleeding on probing ≥20% of sites

          -  Extensive bone loss determined radiographically

        Exclusion Criteria:

          -  Periodontal treatment before the time of examination

          -  Systemic illness

          -  Pregnancy

          -  Anticoagulant, antibiotics and non- steroid anti- inflammatory therapy in the 6-month
             period before the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge Gamonal, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Dentistry of University of Chile</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry of University of Chile</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2014</study_first_submitted>
  <study_first_submitted_qc>November 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2014</study_first_posted>
  <last_update_submitted>June 13, 2016</last_update_submitted>
  <last_update_submitted_qc>June 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Chile</investigator_affiliation>
    <investigator_full_name>Jorge Gamonal</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Chronic periodontitis</keyword>
  <keyword>Probiotics</keyword>
  <keyword>Non- surgical treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

